BOLT BIOTHERAPEUTICS INC shareholders Q2 2023

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 42 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

BOLT BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Hawkeye Capital Management, LLC 415,039$531,2501.00%
Nan Fung Group Holdings Ltd 1,166,952$1,493,6990.96%
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$2,421,0780.80%
TANG CAPITAL MANAGEMENT LLC 3,333,803$4,267,2680.63%
Acuitas Investments, LLC 460,385$589,2930.34%
Vivo Capital, LLC 3,871,291$4,955,2520.34%
Newtyn Management, LLC 1,000,000$1,280,0000.30%
Samsara BioCapital, LLC 1,049,153$1,342,9160.24%
Sofinnova Investments, Inc. 2,754,437$3,525,6790.23%
Privium Fund Management (UK) Ltd 116,516$147,9750.12%
Board of Trustees of The Leland Stanford Junior University 719,546$921,0190.09%
Orbimed Advisors 1,541,000$1,972,4800.04%
Privium Fund Management B.V. 116,516$147,9750.03%
Marquette Asset Management, LLC 97,835$125,2290.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 101,200$129,5360.00%
XTX Topco Ltd 13,309$17,0360.00%
Assenagon Asset Management S.A. 158,289$202,6100.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 500,000$640,0000.00%
Renaissance Technologies 483,939$6190.00%
Citadel Advisors 2,986,147$3,822,2680.00%
External links

This page lists BOLT BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view BOLT BIOTHERAPEUTICS INC's shareholder history, click here.